Angel Investing as corporate venturing within a company concludes the 3-posts mini-series as guest blogger for CURE.
- My first post “Why large organizations struggle to innovate” looked at innovation obstacles in large organizations.
- We discussed an example for an innovation and talent identification engine in the second post, Intrapreneuring: Building an innovation eco-system with the “School for Intrapreneurs”.
- This third post illuminates a very successful implementation of venture capital approach in a large organization to work around “red tape” and get more risky projects funded.
However, it’s not over! Please check in occasionally for more innovation and intrapreneuring-related posts in the future!
CURE serves as the bioscience cluster of Connecticut, a diverse network of small and large life and healthcare sciences companies, ranging in scope from therapeutics, to healthcare technology, to medical devices. Universities, government agencies, scientists, educators, mentors, students, entrepreneurs, business experts, service providers and investors join in to begin nucleate the breadth of the network.
As participants in CURE, we educate, cultivate entrepreneurship, support the build of bioscience companies and collaborate to ensure a sustainable, high-value bioscience and healthcare community that improves our quality of life and keeps the Connecticut community strong.